SMP0062625
View Pathway
|
Propiomazine H1-Antihistamine Action
Homo sapiens
Matched Description: action of histamine at the H1 receptor and are administered to attenuate inflammatory process in order … to treat conditions such as allergic rhinitis, allergic conjunctivitis, and urticaria. Reducing the … activity of the NF-κB immune response transcription factor through the phospholipase C and the … phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression of … pro-inflammatory cytokines, cell adhesion molecules, and chemotactic factors. Furthermore, lowering
|
SMP0062788
View Pathway
|
Clocinizine H1-Antihistamine Action
Homo sapiens
Matched Description: interfere with the agonist action of histamine at the H1 receptor and are administered to attenuate … , and urticaria. Reducing the activity of the NF-κB immune response transcription factor through the … phospholipase C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen … presentation and the expression of pro-inflammatory cytokines, cell adhesion molecules, and chemotactic … barrier and cause sedation and other adverse central nervous system (CNS) effects (e.g. nervousness and
|
SMP0062795
View Pathway
|
Homochlorcyclizine H1-Antihistamine Action
Homo sapiens
Matched Description: the agonist action of histamine at the H1 receptor and are administered to attenuate inflammatory … process in order to treat conditions such as allergic rhinitis, allergic conjunctivitis, and … C and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and … the expression of pro-inflammatory cytokines, cell adhesion molecules, and chemotactic factors … further histamine release. First-generation antihistamines readily cross the blood-brain barrier and
|
SMP0062881
View Pathway
|
Alcaftadine H1-Antihistamine Action
Homo sapiens
Matched Description: the agonist action of histamine at the H1 receptor and are administered to attenuate inflammatory … process in order to treat conditions such as allergic rhinitis, allergic conjunctivitis, and urticaria … and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the … expression of pro-inflammatory cytokines, cell adhesion molecules, and chemotactic factors … histamine release. First-generation antihistamines readily cross the blood-brain barrier and cause
|
SMP0062883
View Pathway
|
Deptropine H1-Antihistamine Action
Homo sapiens
Matched Description: histamine at the H1 receptor and are administered to attenuate inflammatory process in order to … treat conditions such as allergic rhinitis, allergic conjunctivitis, and urticaria. Reducing the … activity of the NF-κB immune response transcription factor through the phospholipase C and the … phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the expression of pro … -inflammatory cytokines, cell adhesion molecules, and chemotactic factors. Furthermore, lowering
|
SMP0058936
View Pathway
|
Hydroxyzine H1-Antihistamine Action
Homo sapiens
Matched Description: agonist action of histamine at the H1 receptor and are administered to attenuate inflammatory … process in order to treat conditions such as allergic rhinitis, allergic conjunctivitis, and urticaria … and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the … expression of pro-inflammatory cytokines, cell adhesion molecules, and chemotactic factors … histamine release. First-generation antihistamines readily cross the blood-brain barrier and cause
|
SMP0058964
View Pathway
|
Buclizine H1-Antihistamine Action
Homo sapiens
Matched Description: agonist action of histamine at the H1 receptor and are administered to attenuate inflammatory process … in order to treat conditions such as allergic rhinitis, allergic conjunctivitis, and urticaria … . Reducing the activity of the NF-κB immune response transcription factor through the phospholipase C and … the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the … expression of pro-inflammatory cytokines, cell adhesion molecules, and chemotactic factors. Furthermore
|
SMP0059058
View Pathway
|
Cetirizine H1-Antihistamine Action
Homo sapiens
Matched Description: agonist action of histamine at the H1 receptor and are administered to attenuate inflammatory … process in order to treat conditions such as allergic rhinitis, allergic conjunctivitis, and urticaria … and the phosphatidylinositol (PIP2) signalling pathways also decreases antigen presentation and the … expression of pro-inflammatory cytokines, cell adhesion molecules, and chemotactic factors … histamine release. First-generation antihistamines readily cross the blood-brain barrier and cause
|
SMP0126580
View Pathway
|
Thiothixene Dopamine Antagonist Action Pathway
Homo sapiens
Matched Description: and D4 - different antipsychotic properties on productive and unproductive symptoms), on serotonergic … -receptors (5-HT1 and 5-HT2, with anxiolytic, antidepressive and antiaggressive properties as well as … pressure, sedation and ejaculation difficulties), on histaminergic-receptors (H1-receptors, sedation … , antiemesis, vertigo, fall in blood pressure and weight gain), alpha1/alpha2-receptors … and incontinence as well as sexual dysfunction, but may also attenuate pseudoparkinsonism
|
SMP0126432
View Pathway
|
Betrixaban Action Pathway
Homo sapiens
Matched Description: Betrixaban is an anticoagulant that targets and inhibits factor Xa in order to prevent venous … thromboembolism. Due to its interaction with factor Xa, the coagulant factor is no longer free and unable … to form the prothrombinase complex. Betrixaban is administered orally and rapidly absorbed, if … eliminated via the gastrointestinal system, feces and urine. Some possible adverse effects are … bleeding, hypersensitivity and minimal hepatotoxicity. The anticoagulant does interact with food, this
|